Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Patients with atrial fibrillation (AF) on long-term oral anticoagulation (OAC) either have underlying coronary artery disease or suffer from acute coronary syndromes necessitating a percutaneous coronary intervention (PCI). In such a scenario, an amalgamation of antiplatelet and antithrombotic thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Akshyaya, Bhandari, Monika, Vishwakarma, Pravesh, Sethi, Rishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609168/
https://www.ncbi.nlm.nih.gov/pubmed/33163856
http://dx.doi.org/10.1055/s-0040-1719081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609168/
https://www.ncbi.nlm.nih.gov/pubmed/33163856
http://dx.doi.org/10.1055/s-0040-1719081

Ejemplares similares